The Cigna Group (LTS:0A77) Research & Development : $0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is The Cigna Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. The Cigna Group's Research & Development for the three months ended in Mar. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was $0 Mil.

The Cigna Group Research & Development Historical Data

The historical data trend for The Cigna Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cigna Group Research & Development Chart

The Cigna Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

The Cigna Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

The Cigna Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

The Cigna Group (LTS:0A77) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Cigna Group Research & Development Related Terms

Thank you for viewing the detailed overview of The Cigna Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cigna Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » The Cigna Group (LTS:0A77) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

CI:USA CI:Mexico CGN:Germany C1IC34:Brazil CIGN:Austria

Address

900 Cottage Grove Road, Bloomfield, CT, USA, 06002

Website

https://www.cigna.com

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

The Cigna Group Headlines

No Headlines